JENNIFER GARREN: Open Payments
NPI 1851833974 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 66 payments from 16 companies in 2025. Trend: 2023 $458 · 2024 $279 · 2025 $1,134
Food & beverage: $1,091Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $274 |
| Janssen Biotech, Inc. | 15 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $97 |
| PFIZER INC. | 5 | $76 |
| QOL Medical, LLC | 2 | $69 |
| Ardelyx, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 6 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Gilead Sciences, Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $31 |
Products named: TREMFYA, RINVOQ, ENTYVIO, Sucraid, CREON, LINZESS, IBSRELA, DUPIXENT.
Industry payments across SC — which companies pay providers there.
